ASF1B and cancer: In previous studies, ASF1B has been found to promote the growth of myeloma (Misiewicz-Krzeminska et al., 2013; Wang et al., 2020), glioma (Zhang and Liu, 2023), and cancers in breast (Corpet et al., 2011), kidney (Chen et al., 2020), prostate (Carrion et al., 2020), bladder (Zhang et al., 2024) cervical (Xu et al., 2019; Liu et al., 2020), lung (Zhang et al., 2021; Song et al., 2024), liver (Zhang et al., 2022a), and stomach (Zhao et al., 2024; Zhang et al., 2023) as an oncogene.